Jonathan Roberts is a Registered Genetic Counsellor at Addenbrooke’s Hospital in Cambridge and a Researcher at the Society and Ethics […]
A recent GWAS analysis in the Middle Eastern Qatari population has identified genetic associations in 45 clinically relevant traits. GWAS […]
An understanding of the environmental and genetic risk of Alzheimer’s Disease is vital for the production of more effective therapies. […]
Genome UK The UK has launched its new National Genomic Healthcare Strategy, with the goal of cementing its status as […]
As part of the 20th anniversary of Nature Reviews Genetics, Professor Ambroise Wonkam from the University of Cape Town has […]
We know from twin studies that Schizophrenia carries a 80% heritability risk, but haven’t yet managed to deduce exact genetic […]
Rory Collins, Principal Investigator and Chief Executive of UK Biobank leads this landmark project. We talk to him about some of the research outcomes from UK Biobank, and why he’s excited to be speaking at the Festival of Genomics this January.
In a recent study published in Nature, researchers used Diffusion Tensor Imaging (DTI) data (a type of MRI scan) to […]
Researchers have employed an extreme phenotype strategy to focus on the most severely affected individuals with schizophrenia and subsequently identified […]
Giles Yeo is a Principal Research Associate at MRC Metabolic Diseases Unit and the Scientific Director of the Genomics/Transcriptomics Core […]
